Jefferies Downgrades Pacira BioSciences to Hold, Announces $36 Price Target

Benzinga · 4d ago
Jefferies analyst Glen Santangelo downgrades Pacira BioSciences (NASDAQ:PCRX) from Buy to Hold and announces $36 price target.